Olarn Roengvoraphoj

695 total citations
34 papers, 476 citations indexed

About

Olarn Roengvoraphoj is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Olarn Roengvoraphoj has authored 34 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Olarn Roengvoraphoj's work include Lung Cancer Diagnosis and Treatment (17 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Treatments and Mutations (14 papers). Olarn Roengvoraphoj is often cited by papers focused on Lung Cancer Diagnosis and Treatment (17 papers), Lung Cancer Research Studies (15 papers) and Lung Cancer Treatments and Mutations (14 papers). Olarn Roengvoraphoj collaborates with scholars based in Germany, Sweden and United States. Olarn Roengvoraphoj's co-authors include Chukwuka Eze, Claus Belka, Farkhad Manapov, Lukas Käsmann, Maximilian Niyazi, Julian Taugner, Nina-Sophie Schmidt-Hegemann, Amanda Tufman, Minglun Li and Sebastian Marschner and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Olarn Roengvoraphoj

32 papers receiving 472 citations

Peers

Olarn Roengvoraphoj

PRM

ONCOL

RNMI

EPIDE

GENET

Valentina Borzillo Italy

Takeaki Ishihara Japan

Lena M. Mittlmeier Germany

Daniele Scartoni Italy

Joseph Sia Australia

Paula Wells United Kingdom

C. Terhaard Netherlands

Jason C. Ye United States

Jaymin Jhaveri United States

Takuya Kaminuma Japan

Valentina Borzillo Italy

Olarn Roengvoraphoj

196 ×0.6

PRM

352 ×1.4

ONCOL

139 ×0.9

RNMI

39 ×0.5

EPIDE

35 ×0.8

GENET

Citations per year, relative to Olarn Roengvoraphoj Olarn Roengvoraphoj (= 1×) peers Valentina Borzillo

Countries citing papers authored by Olarn Roengvoraphoj

Since Specialization

Citations

This map shows the geographic impact of Olarn Roengvoraphoj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olarn Roengvoraphoj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olarn Roengvoraphoj more than expected).

Fields of papers citing papers by Olarn Roengvoraphoj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olarn Roengvoraphoj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olarn Roengvoraphoj. The network helps show where Olarn Roengvoraphoj may publish in the future.

Co-authorship network of co-authors of Olarn Roengvoraphoj

This figure shows the co-authorship network connecting the top 25 collaborators of Olarn Roengvoraphoj. A scholar is included among the top collaborators of Olarn Roengvoraphoj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olarn Roengvoraphoj. Olarn Roengvoraphoj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hadi, Indrawati, D. Reitz, Raphael Bodensohn, et al.. (2021). Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas. Radiation Oncology. 16(1). 40–40. 3 indexed citations

Hadi, Indrawati, Olarn Roengvoraphoj, Raphael Bodensohn, et al.. (2020). Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis. Radiation Oncology. 15(1). 37–37. 31 indexed citations

Käsmann, Lukas, Chukwuka Eze, Julian Taugner, et al.. (2020). Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy. Radiation Oncology. 15(1). 167–167. 30 indexed citations

Hoffmann, Michael M., D. Reitz, Julian Taugner, et al.. (2020). Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy. Anticancer Research. 40(4). 2319–2322. 4 indexed citations

Käsmann, Lukas, Chukwuka Eze, Julian Taugner, et al.. (2020). External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy. Lung. 198(1). 201–206. 3 indexed citations

Roengvoraphoj, Olarn, Lukas Käsmann, Chukwuka Eze, et al.. (2020). Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy. Translational Lung Cancer Research. 9(3). 541–548. 6 indexed citations

Käsmann, Lukas, Julian Taugner, Chukwuka Eze, et al.. (2020). Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. Radiation Oncology. 15(1). 5–5. 26 indexed citations

Käsmann, Lukas, Julian Taugner, Chukwuka Eze, et al.. (2019). Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment. Anticancer Research. 39(9). 5077–5081. 20 indexed citations

Eze, Chukwuka, Julian Taugner, Olarn Roengvoraphoj, et al.. (2019). Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis. Radiation Oncology. 14(1). 163–163. 8 indexed citations

10.

Käsmann, Lukas, Chukwuka Eze, Olarn Roengvoraphoj, et al.. (2019). State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours—a German radiation oncology survey. European Journal of Cancer. 108. 50–54. 16 indexed citations

11.

Manapov, Farkhad, Lukas Käsmann, Olarn Roengvoraphoj, et al.. (2018). Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes. PubMed. Volume 9. 49–55. 27 indexed citations

12.

Eze, Chukwuka, Olarn Roengvoraphoj, Lukas Käsmann, et al.. (2018). Prophylactic Cranial Irradiation for Patients with Small Cell Lung Cancer in Germany: Pattern of Care Survey. Anticancer Research. 38(9). 5261–5265. 3 indexed citations

13.

Roengvoraphoj, Olarn, Chukwuka Eze, Julian Taugner, et al.. (2018). How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience. European Journal of Nuclear Medicine and Molecular Imaging. 45(12). 2103–2109. 14 indexed citations

14.

Roengvoraphoj, Olarn, et al.. (2017). Symptomatic pneumonitis in the irradiated lung after nivolumab: Three case studies. Annals of Oncology. 28. ii42–ii42. 1 indexed citations

15.

Eze, Chukwuka, Olarn Roengvoraphoj, & Farkhad Manapov. (2017). Prophylactic Cranial Irradiation in Resected Early-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(3). 612–614. 9 indexed citations

16.

Eze, Chukwuka, et al.. (2017). Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature. Frontiers in Oncology. 7. 88–88. 8 indexed citations

17.

Hadi, Indrawati, Olarn Roengvoraphoj, Maximilian Niyazi, et al.. (2017). Medulloblastoma in adults. Strahlentherapie und Onkologie. 194(3). 225–234. 9 indexed citations

18.

Roengvoraphoj, Olarn, Chukwuka Eze, Minglun Li, et al.. (2017). Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer. Strahlentherapie und Onkologie. 194(2). 107–115. 21 indexed citations

19.

Manapov, Farkhad, Maximilian Niyazi, S. Gerum, et al.. (2016). Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy. BMC Cancer. 16(1). 216–216. 6 indexed citations

20.

Manapov, Farkhad, Chukwuka Eze, Maximilian Niyazi, et al.. (2016). Investigating a Correlation between Chemoradiotherapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort. Journal of Cancer. 7(14). 2012–2017. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact